Prognostic factors for death due to invasive aspergillosis after hematopoietic stem cell transplantation: a 1-year retrospective study of consecutive patients at French transplantation centers.
about
Recent developments in the management of invasive fungal infections in patients with oncohematological diseasesEpidemiology of invasive candidiasis: a persistent public health problemPre-medication practices and incidence of infusion-related reactions in patients receiving AMPHOTEC: data from the Patient Registry of Amphotericin B Cholesteryl Sulfate Complex for Injection Clinical Tolerability (PRoACT) registry.Factors associated with mortality in transplant patients with invasive aspergillosisEfficacy of itraconazole prophylaxis for autologous stem cell transplantation in children with high-risk solid tumors: a prospective double-blind randomized study.Deletion of the regulatory subunit of protein kinase A in Aspergillus fumigatus alters morphology, sensitivity to oxidative damage, and virulence.CD4+ T cells mediate the protective effect of the recombinant Asp f3-based anti-aspergillosis vaccine.Outcome analysis of invasive aspergillosis in hematologic malignancy and hematopoietic stem cell transplant patients: the role of novel antimold azolesIdiopathic pneumonia syndrome after hematopoietic cell transplantation: evidence of occult infectious etiologiesSafety and efficacy of a caspofungin-based combination therapy for treatment of proven or probable aspergillosis in pediatric hematological patientsBaseline platelet count and creatinine clearance rate predict the outcome of neutropenia-related invasive aspergillosis.Persistent poor long-term prognosis of allogeneic hematopoietic stem cell transplant recipients surviving invasive aspergillosis.Protective Effector Cells of the Recombinant Asp f3 Anti-Aspergillosis Vaccine.A Prospective, International Cohort Study of Invasive Mold Infections in Children.Strategies to enhance immune function in hematopoietic transplantation recipients who have fungal infections.Role of Granulocyte-Macrophage Colony-Stimulating Factor Signaling in Regulating Neutrophil Antifungal Activity and the Oxidative Burst During Respiratory Fungal Challenge.Advances in the serological diagnosis of invasive Aspergillus infections in patients with haematological disorders.Epidemiology, outcomes, and mortality predictors of invasive mold infections among transplant recipients: a 10-year, single-center experience.Risks, diagnosis and outcomes of invasive fungal infections in haematopoietic stem cell transplant recipients.Changing landscape of invasive aspergillosis in allogeneic stem cell transplant recipients.When primary antifungal therapy fails.Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016.Distinct responses of human monocyte subsets to Aspergillus fumigatus conidiaPinpointing prognostic indicators of fungal infections in transplant patients.Risk factors for early mortality in haematological malignancy patients with pulmonary mucormycosis.Clinical and economic burden of invasive fungal diseases in Europe: focus on pre-emptive and empirical treatment of Aspergillus and Candida species.Diagnosis and treatment of fungal infections in allogeneic stem cell and solid organ transplant recipients.Primary antifungal prophylaxis in acute myeloblastic leukemia and myelodysplastic syndrome--still an open question?Antifungal treatment strategies in patients with haematological diseases or cancer: from prophylaxis to empirical, pre-emptive and targeted therapy.Economic considerations in the treatment of invasive aspergillosis: a review of voriconazole pharmacoeconomic studies.Risk Factors and Outcomes of Invasive Fungal Infections in Allogeneic Hematopoietic Cell Transplant Recipients.Prospective evaluation of the cost of diagnosis and treatment of invasive fungal disease in a cohort of adult haematology patients in the UK.Prospective evaluation of the SeptiFAST multiplex real-time PCR assay for surveillance and diagnosis of infections in haematological patients after allogeneic stem cell transplantation compared to routine microbiological assays and an in-house real-What are fungal infections?Randomized PCR-based therapy and risk factors for invasive fungal infection following reduced-intensity conditioning and hematopoietic SCT.An EORTC Phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patients.Invasive fungal disease in allogeneic hematopoietic stem cell transplant recipients: an autopsy-driven survey.Lower respiratory tract respiratory virus infections increase the risk of invasive aspergillosis after a reduced-intensity allogeneic hematopoietic SCT.Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.Risk factors for invasive aspergillosis and related mortality in recipients of allogeneic SCT from alternative donors: an analysis of 306 patients.
P2860
Q28077381-F45E566B-F1E9-40C0-8BD0-123D3E9872DDQ29616758-E8418673-461A-439F-A64D-A9B972B3F909Q33371455-3409B6CC-7929-4DEA-B2E8-9920AD7C196BQ33867013-720BF9F0-56C3-42D2-89F7-DA20BC631A9FQ34635418-3D1B4D49-2B9D-4BAE-8F13-E4589087346FQ34975764-91EB6E7B-DE7D-4507-965F-CC36C7CC95B8Q35075750-2BB8BD31-7747-473A-8032-5C3E8662C9ABQ35584615-649C0193-E693-4A98-B80B-527FEA0AD0A3Q35724040-DB08E192-B9CB-44C5-B86B-05A7B9C797E5Q35799730-F21F3483-83A3-4AB7-BC96-387205BE23D5Q36115615-EF086ED7-4C74-48A4-B36F-D6D2480F9136Q36216209-3AFC4700-E943-4EAE-ACED-ECB8D7F87B10Q36231936-2F267B1A-B445-429A-B99A-E3CBD3E53D25Q36377386-180ADB93-DA93-493F-9A18-D53E4DE5C223Q36568458-BB9454D2-F9D9-4FA5-B31C-C1FB9C58DA85Q36705885-C401A4D0-6551-4264-8470-5012748DCA86Q36774247-B2927D8E-192F-4F1F-B851-025245F6F422Q36876327-2ED094FB-328E-4BFA-9298-FD871AD66190Q36990751-D61EEC1D-247C-47C8-8268-83171BD07F18Q37081683-CF3027FB-5A91-4AD0-9A00-3239F0704773Q37141191-FE4D967F-A4CF-4021-B62D-2F8A2805C983Q37150434-00A7BCEE-36FB-4C7D-B098-951C1ECF64C8Q37367171-37709CD8-E39C-44EC-8711-DBD9E85985CAQ37389541-C10AC874-7A5E-4D8B-BDE6-B3144A74B92BQ37402238-B2156CBD-56BE-44F3-BDAA-86FEE5C28BDAQ37480190-12CF01A3-31A5-4A07-B0CE-CFB2914DE2EAQ37650317-0F27B013-6665-480F-8BDF-8A9DE647FB93Q37657464-1CFE84C5-BB29-478D-84B5-455AB7D9742DQ37873552-710442BA-0DF0-4CE6-9DA9-6990DE30ECB1Q37936259-BF23B38C-CD0A-4731-A85E-4A9D2EF2A73CQ40357629-B562BF10-B722-4ED8-8AC4-F25EB09C2D5AQ41656144-718FF24D-0AC1-43E5-9B54-F700E7E3DE17Q41929754-2228DBDF-E825-4535-8AFE-F9FB0C86C551Q42148730-08B6B6FA-4F4C-4CD6-88CD-37CE4EBAD1E5Q43146785-153408E8-7572-4133-BCC8-32E48045DCA9Q43258660-46F56B79-B182-46B8-A01F-BCCB91280D16Q45018793-6252EF29-3A0F-4CCC-8302-205BBF36AC22Q45385030-375375FC-5652-442D-B149-B6B6EBB23251Q45938423-85FBC8CB-3BA6-49C4-8505-01C2DF0C8A2FQ46077878-B854977C-B02C-4092-847F-BF82FA3D69EB
P2860
Prognostic factors for death due to invasive aspergillosis after hematopoietic stem cell transplantation: a 1-year retrospective study of consecutive patients at French transplantation centers.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Prognostic factors for death d ...... rench transplantation centers.
@en
type
label
Prognostic factors for death d ...... rench transplantation centers.
@en
prefLabel
Prognostic factors for death d ...... rench transplantation centers.
@en
P2093
P356
P1476
Prognostic factors for death d ...... rench transplantation centers.
@en
P2093
Amath Wade
Caroline Morgan
Catherine Cordonnier
Noël Milpied
Patricia Ribaud
Société Française de Greffe de Moelle et de Thérapie Cellulaire
P304
P356
10.1086/500934
P407
P577
2006-02-22T00:00:00Z